As of November 2024, Marksans Pharma has a market cap of $1.50B. This makes Marksans Pharma the world's 6174th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $864.65M | 0.56% |
2023 | $859.85M | 176.57% |
2022 | $310.90M | -3.16% |
2021 | $321.04M | -0.82% |
2020 | $323.71M | 263.17% |
2019 | $89.13M | -40.04% |
2018 | $148.65M | -30.29% |
2017 | $213.23M | 0.25% |
2016 | $212.69M | -61.94% |
2015 | $558.82M | 70.38% |
2014 | $327.98M | 249.15% |
2013 | $93.94M | 417.65% |
2012 | $18.15M | 100.00% |
2011 | $9.07M | -54.05% |
2010 | $19.75M | -35.09% |
2009 | $30.42M | -21.92% |
2008 | $38.96M | -76.51% |
2007 | $165.86M | 188.13% |
2006 | $57.56M | -48.66% |
2005 | $112.11M | 15.35% |
2004 | $97.19M | 247.19% |
2003 | $27.99M | 118.54% |
2002 | $12.81M | - |